TILE HOUSE SURGERY — All Prescriptions & Medications — Page 12
Practice Code: F81038 | BRENTWOOD, CM15 8AQ
Showing results 551-600 of 622
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Metformin hydrochloride/sitagliptin | 14 | 1,568 | £276 | -62.6% ▼ |
| Raloxifene hydrochloride | 14 | 392 | £55 | -5.2% ▼ |
| Clindamycin phosphate | 14 | 560 | £145 | +235.6% ▲ |
| Fesoterodine fumarate | 14 | 532 | £43 | -64.5% ▼ |
| Cyproterone acetate | 14 | 427 | £513 | +27.5% ▲ |
| Pyridoxine hydrochloride | 14 | 1,332 | £607 | -34.9% ▼ |
| Pyridostigmine bromide | 14 | 3,600 | £288 | -18.2% ▼ |
| Betamethasone sodium phosphate | 14 | 170 | £39 | -46.0% ▼ |
| Azelastine hydrochloride | 14 | 152 | £116 | +17.8% ▲ |
| Amiloride hydrochloride | 13 | 420 | £215 | -48.4% ▼ |
| Lisinopril with diuretic | 13 | 364 | £125 | -36.6% ▼ |
| Fluvastatin sodium | 13 | 728 | £95 | -43.8% ▼ |
| Ipratropium bromide | 13 | 253 | £123 | -54.8% ▼ |
| Amisulpride | 13 | 546 | £197 | -81.5% ▼ |
| Itraconazole | 13 | 560 | £222 | -3.1% ▼ |
| Betamethasone sodium phosphate | 13 | 1,570 | £208 | +5.7% ▲ |
| Other compound vitamin/mineral formulation preparations | 13 | 364 | £38 | -59.5% ▼ |
| Diclofenac sodium | 13 | 2,600 | £140 | +22.2% ▲ |
| Tafluprost and timolol | 13 | 780 | £377 | -32.3% ▼ |
| Clindamycin phosphate | 13 | 450 | £110 | -21.0% ▼ |
| 13 | 263 | £965 | -38.5% ▼ | |
| 13 | 89 | £229 | -46.3% ▼ | |
| 13 | 43 | £694 | -5.9% ▼ | |
| 13 | 690 | £1.2K | -12.5% ▼ | |
| 13 | 109 | £171 | -21.2% ▼ | |
| 13 | 1,410 | £962 | +16.9% ▲ | |
| Sucralfate | 12 | 3,752 | £4.5K | +42.9% ▲ |
| Cilostazol | 12 | 1,176 | £685 | -13.5% ▼ |
| Acenocoumarol | 12 | 1,200 | £53 | +21.3% ▲ |
| Nefopam hydrochloride | 12 | 1,080 | £46 | -89.4% ▼ |
| Frovatriptan | 12 | 174 | £414 | -15.1% ▼ |
| Perampanel | 12 | 336 | £1.6K | -44.6% ▼ |
| Repaglinide | 12 | 1,176 | £65 | -50.4% ▼ |
| Meloxicam | 12 | 332 | £10 | -81.9% ▼ |
| Hepatitis B | 12 | 12 | £187 | +13.4% ▲ |
| 12 | 469 | £313 | -12.2% ▼ | |
| 12 | 31 | £284 | -25.0% ▼ | |
| 12 | 415 | £730 | -32.4% ▼ | |
| 12 | 19 | £1.9K | +37.8% ▲ | |
| 12 | 160 | £227 | +83.1% ▲ | |
| 12 | 2,460 | £1.7K | +92.5% ▲ | |
| 12 | 1,080 | £3.4K | -1.5% vs avg | |
| 12 | 1,750 | £159 | -74.6% ▼ | |
| Dicycloverine hydrochloride | 11 | 1,100 | £959 | -7.1% ▼ |
| Valsartan | 11 | 728 | £165 | -81.3% ▼ |
| Prasugrel | 11 | 597 | £82 | -65.0% ▼ |
| Umeclidinium bromide | 11 | 11 | £288 | -82.2% ▼ |
| Sulpiride | 11 | 1,800 | £674 | -58.9% ▼ |
| Flupentixol decanoate | 11 | 110 | £168 | -31.1% ▼ |
| Modafinil | 11 | 630 | £42 | -47.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.